Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

Name: Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Brand: Glaxo Smith Kline
SKU: USAMP#67317086
Price: 2223.29 USD
Availability: InStock

USAMP#67317086SKU: 58160082730Menveo®

License Required

Product Spotlight

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135
MENVEO does not prevent N. meningitidis serogroup B infections
Single-vial presentation

Product Spotlight

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135
MENVEO does not prevent N. meningitidis serogroup B infections
Single-vial presentation